Tiova Inhaler 9 mcg – Effective COPD & Asthma Management
Tiova Inhaler contains Tiotropium Bromide 9 mcg, a long-acting bronchodilator used to manage chronic obstructive pulmonary disease (COPD), emphysema, and asthma. Manufactured by Cipla, it delivers consistent relief by relaxing airway muscles and making breathing easier.
What is Tiova Inhaler Used For?
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma and emphysema
- Bronchospasm prevention
- Long-term maintenance therapy for chronic lung issues
How Does Tiova Work?
Tiotropium Bromide works by inhibiting cholinergic receptors in the lungs, which helps open airways. It is not a rescue inhaler but a maintenance treatment taken once daily to reduce breathlessness and flare-ups.
Dosage & Administration
Use one inhalation once daily, or as directed by your physician. Always rinse your mouth after use to prevent dryness or oral infections.
Why Choose Tiova Inhaler from genericurerx?
- Authentic Cipla product
- Fast & discreet worldwide shipping
- Affordable pricing
- Trusted by customers in the USA, UK, Australia, and more
Buy Tiova Inhaler 9 mcg online now and breathe easier with genericurerx’s trusted pharmacy network.
Precautions
- Not for use as a rescue inhaler
- Consult your doctor if pregnant, breastfeeding, or using other medications
- May cause dry mouth or dizziness – stay hydrated and avoid driving if affected
Side Effects
Common side effects include dry mouth, sore throat, cough, and dizziness. Rare side effects may include urinary retention or eye pain. If any severe symptoms occur, consult your healthcare provider immediately.
FAQs
1. Is Tiova Inhaler the same as Spiriva?
Tiova is a generic equivalent to Spiriva, both containing Tiotropium Bromide.
2. How long does one Tiova Inhaler last?
One inhaler provides 200 metered doses—sufficient for approximately 6 to 7 months when used daily.
3. Can Tiova be used with other inhalers?
Yes, but always consult a doctor before combining inhalers for asthma or COPD treatment.


Reviews
There are no reviews yet.